We have investigated renin inhibitory activity in relation to the chemical composition of several phospholipids, especially those isolated from an organic fraction of dog kidneys reported to contain a phosphatidyl amino acid renin 'preinhibitor'. In our hands, this fraction, eluted from a silicic acid column with chloroform–methanol (4:1), contained large amounts of phosphatidylthanolamine (PE) as established by infrared spectroscopy, silica gel, paper, and gas–liquid chromatography, elemental analysis, and specific stains. No other ninhydrin-positive phospholipid migrating as 'preinhibitor' on thin-layer chromatographs was detected, with the possible exception of a very minor, unidentified, ethanolamine-positive component. Also eluted with the PE was lyso PE, in a quantity (0.16 mg/g kidney) within the range originally reported for 'preinhibitor'. But coidentity of 'preinhibitor' and lyso PE is unlikely since the latter is deacylated, contains ethanolamine and a much higher percentage (66 mol %) of arachidonate in its esterified fatty acids, and does not inhibit renin in vitro. Dog and rat kidney PE, and, most potently, ox brain phosphatidylserine, all inhibited renin in vitro, but not in vivo. These data argue against the existence and proposed structure of the renal renin 'preinhibitor', and also against the concept of a unique inhibitory role of a specific base moiety and fatty acid composition. Lack of in vivo renin inhibition using the infusion technique by which such inhibition was originally demonstrated questions the relevance of the tested phospholipids as physiological regulators of the rennin–angiotensin system.